Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GDC-0834 inhibits BTK with an in vitro IC50 of 5.9 and 6.4 nM in biochemical and cellular assays, respectively, and in vivo IC50 of 1.1 and 5.6 μM in mouse and rat, respectively. GDC-0834 is a potent and selective BTK inhib
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
2 mg | 約5 days | ¥ 45,500 |
5 mg | 約5 days | ¥ 91,500 |
1 mL * 10 mM (in DMSO) | 約5 days | ¥ 125,500 |
ターゲット&IC50 | BTK:5.9 nM |
In vivo | In a rat collagen-induced arthritis (CIA) study, GDC-0834 exhibits a dose-dependent inhibition of phosphorylated Bruton's tyrosine kinase (pBTK-Tyr223) in rat blood. The estimated half-maximal inhibitory concentration (IC50) for pBTK-Tyr223 inhibition in rats is 5.6±1.6 μM, demonstrating a moderate potency with a mean (m) value of 0.51±0.087. Furthermore, treatment with GDC-0834 in BALB/c mice demonstrates dose-dependent suppression of pBTK-Tyr223, with dosages of 150 or 100 mg/kg achieving nearly complete inhibition (97% and 96%, respectively) of pBTK-Tyr223 levels in the blood after 2 hours. |
分子量 | 596.74 |
分子式 | C33H36N6O3S |
CAS No. | 1133432-49-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 32 mg/mL (53.62 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GDC-0834 1133432-49-1 Angiogenesis Tyrosine Kinase/Adaptors BTK GDC0834 GDC 0834 Inhibitor inhibitor inhibit